Iron Sucrose Injection is a sterile intravenous iron preparation used for the treatment of iron deficiency anemia, particularly in patients who are unable to tolerate oral iron therapy or in whom oral iron is ineffective. It contains iron in the form of a complex of polynuclear iron (III)-hydroxide in sucrose, which allows controlled delivery of iron directly into the bloodstream. This injection is commonly prescribed for patients with chronic kidney disease (CKD), especially those undergoing hemodialysis, as well as for individuals with severe anemia during pregnancy, postpartum anemia, or cases where rapid iron replenishment is required. Iron sucrose works by replenishing iron stores in the body, which are essential for the production of hemoglobin—the protein in red blood cells responsible for carrying oxygen throughout the body. By restoring iron levels, it helps improve hemoglobin concentration, reduce symptoms such as fatigue, weakness, dizziness, and shortness of breath, and enhance overall energy levels and physical performance. The injection is administered intravenously under medical supervision, either as a slow injection or infusion, depending on the prescribed dosage and patient condition. Dosage and duration of therapy are determined by the severity of anemia, body weight, and laboratory parameters such as hemoglobin and serum ferritin levels. Common side effects may include temporary changes in taste, nausea, headache, muscle cramps, injection site reactions, or low blood pressure, while serious allergic reactions are rare but possible, requiring immediate medical attention. Iron sucrose is generally considered safe and effective when administered correctly and is widely used in hospital and clinical settings as part of comprehensive anemia management programs.
